Contrast-enhanced sonography in the characterization of small hepatocellular carcinomas in cirrhotic patients: Comparison with contrast-enhanced ultrafast magnetic resonance imaging

Anticancer Research

Volumn 27, Issue 6 C, 2007, Pages 4263-4269

  Giorgio, Antonio ^a   De Stefano, Giorgio ^a   Coppola, Carmine ^a   Ferraioli, Giovanna ^a   Esposito, Vincenzo ^a,c   Di Sarno, Antonella ^a   Giorgio, Valentina ^a   De Stefano, Manuela ^a   Sangiovanni, Vincenzo ^a   Liorre, Giulia ^a,b   Del Viscovo, Luca ^b  

^a AO Dei Colli Hospital for Infectious Diseases D Cotugno   (Italy)

^b SECOND UNIVERSITY OF NAPLES   (Italy)

^c International Society for the Study of Comparative Oncology ISSCO   (United States)

Author keywords

Cirrhosis; Comparative studies; Contrast media; Hepatocellular carcinoma; Microbubbles; Ultrasound

Indexed keywords

SONOVUE;

ADULT; AGED; ARTICLE; ECHOGRAPHY; FEMALE; HEMANGIOMA; HUMAN; HUMAN TISSUE; INTERMETHOD COMPARISON; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER NODULE; MAJOR CLINICAL STUDY; MALE; NODULAR HYPERPLASIA; NONHODGKIN LYMPHOMA; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; STEATOSIS;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, HEPATOCELLULAR; CONTRAST MEDIA; FEMALE; GADOLINIUM; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; LIVER CIRRHOSIS; LIVER NEOPLASMS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; PHOSPHOLIPIDS; SENSITIVITY AND SPECIFICITY; SULFUR HEXAFLUORIDE; ULTRASONOGRAPHY;

EID: 37549038592     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Bosch FX, Ribes J and Borras J: Epidemiology of primary liver cancer. Semin Liver Dis 19: 271-285, 1999.
2. Colombo M: Hepatocellular carcinoma. J Hepatol 15: 225-236, 1992.
3. Llovet JM and Beaugrand M: Hepatocellular carcinoma: present status and future prospects. J Hepatol 38: S136-149, 2003.
4. Hayashi M, Matsui O, Ueda K, Kawamori Y, Gabata T and Kadoya M: Progression to hypervascular hepatocellular carcinoma: correlation with intranodular blood supply evaluated with CT during intraarterial injection of contrast material. Radiology 225: 143-149, 2002.
5. Lee HM, Lu DS, Krasny RM, Busuttil R, Kadell B and Lucas J: Hepatic lesion characterization in cirrhosis: significance of arterial hypervascularity on dual-phase helical CT. AJR 169: 125-130, 1997.
6. Huppertz A, Balzer T, Blakeborough A, Breuer J, Giovagnoni A, Heinz-Peer G, Laniado M, Manfredi RM, Mathieu DG, Mueller D, Reimer P, Robinson PJ Strotzer M Taupitz M and Vogl TJ: Improved detection of focal liver lesions at MR Imaging: mulficenter comparison of gadoxetic acid-enhanced MR images with intraoperative findings. Radiology 230: 266-275, 2004.
7. Szklaruk J, Silverman PM and Charnsangavej C: Imaging in the diagnosis, staging, treatment, and surveillance of hepatocellular carcinoma. AJR 180: 441-454, 2003.
8. Brancatelli G, Baron RL, Peterson MS and Marsh W: Helical CT screening for hepatocellular carcinoma in patients with cirrhosis: frequency and causes of false-positive interpretation. AJR 180: 1007-1014, 2003.
9. Peterson MS, Baron RL, Murakami T: Hepatic malignancies: usefulness of acquisition of multiple arterial and portal venous phase images at dynamic gadolinium-enhanced MR imaging. Radiology 201: 337-345, 1996.
10. Braga L, Guller U and Semelka RC: Modern hepatic imaging. Surg Clin North Am 84: 375-400, 2004.
11. Burrel M, Llovet JM, Ayuso C, Ayuso C, Iglesias C, Sala M, Miguel R, Caralt T, Ayuso JR, Sole M, Sanchez M, Bru C and Bruix J: Barcelona Clinic Liver Cancer Group: MR Angiography is superior to helical CT for detection of HCC prior to hepatic tansplantation: an explant correlation. Hepatology 38: 1034-1042, 2003.
12. Public Statement on SonoVue (Sulphur hexafluoride): New contraindication in patients with heart disease; restriction of use to non-cardiac imaging. EMEA (European Agency for the Evaluation of Medical Products), http://www.emea.eu/ pdfs/ human/press/pus/021204en.pdf, website, May 19, 2004.
13. Wanless I, Callea F and Craig JR: Terminology of nodular lesions of the liver: recommendations of the World Congress of Gastroenterology Working Party. Hepatology 22: 983-993, 1995.
14. Rofsky NM, Lee VS, Laub G, PollacK MA, Krinsky GA, Thomasson D, Ambrosino MM and Weinreb JC: Abdominal MR imaging with a volumetric interpolated breath-hold examination. Radiology 212: 876-884, 1999.
15. Wilson SR, Burns PN, Muradali D, Wilson JA and Lai X: Harmonic hepatic US with microbubble contrast agent: initial experience showing improved characterization of hemangioma, hepatocellular carcinoma, and metastasis. Radiology 215: 153-161, 2000.
16. Giorgio A, Ferraioli G, Tarantino L, de Stefano G, Scala V, Scarano F, Coppola C and Del Viscovo L: Contrast-enhanced sonographic appearance of hepatocellular carcinoma in cirrhotic patients: comparison with contrast-enhanced helical CT. AJR 183: 1319-1326, 2004.
17. Rode A, Bancel B, Douek P, Chevallier M, Vilgrain V, Picaud G, Henry L, Berger F, Bizollon T, Gaudin JL and Ducerf C: Small nodule detection in cirrhotic livers: evaluation with US, spiral CT, and MRI and correlation with pathologic examination of explanted liver. J Comput Assist Tomogr 25: 327-336, 2001.
18. Okuda K: Hepatocellular carcinoma. J Hepatol 32(S1): 225-237, 2002.
19. Nakashima Y, Nakashima O, Hsia CC, Kojiro M and Tabor E: Vascularization of small hepatocellular carcinoma: correlation with differentiation. Liver 19: 12-18, 1999.
20. Caturelli E, Pompili M, Bartolucci F, Siena DA, Sperandeo M, Andriulli A and Bisceglie M: Hemangioma-like lesions in chronic liver disease: diagnostic evaluation in patients. Radiology 220: 337-342, 2001.
21. Bruix J, Sherman M, Llovet JM, Beaugrand M, Lencioni R, Burroughs AK, Christensen E, Pagliaro L, Colombo M and Rodes J: Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL Conference. J Hepatol 35: 421-430, 2001.
22. Bhartia B, Ward J, Guthrie JA and Robinson PJ: Hepatocellular carcinoma in cirrhotic livers: double-contrast thin-section MR imaging with pathologic correlation of explanted tissue. AJR 180: 577-584, 2003.
23. Glenn A, Krinsky GA, Lee VS, Thiese ND, Glenn A, Theise N, Weinreb JC, Rofsky NM, Diflo T and Teperman LW: Hepatocellular carcinoma and dysplastic nodules in patients with cirrhosis: prospective diagnosis with MR imaging and explantation correlation. Radiology 219: 445-454, 2001.
24. Spinosa DJ, Kaufmann JA and Hartwell GD: Gadolinium chelates in angiography and interventional radiology: a useful alternative to iodinated contrast media for angiography. Radiology 223: 319-325, 2002.
25. Youk JH, Kim CS and Lee JM: Contrast-enhanced agent detection imaging: value in the characterization of focal hepatic lesions. J Ultrasound Med 22: 897-910, 2003.
26. Brannigan M, Burns PN and Wilson SR: Blood flow patterns in focal liver lesions at microbubble-enhanced US. RadioGraphics 24: 921-935, 2004.
27. Caturelli E, Solmi L, Anti M, Fusilli S, Roselli P, Andriulli A, Fornari F, Del Vecchio Blanco C and De Sio I: Ultrasound-guided fine-needle biopsy of early HCC complicating liver cirrhosis: a multicenter study. Gut 53: 1356-1362, 2004.